Fenofibrate Tablet
Product Images NDC 51655-009

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 51655-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fenofibrate-tablet-1 (Fenofibrate Tablets 54 mg And 160 mg 0115 1)

Fenofibrate-tablet-1 (Fenofibrate Tablets 54 mg And 160 mg 0115 1)
Chemical structure diagram of fenofibrate, showing its molecular framework including a chlorophenyl group, ester bonds, and ketone functional groups.*
FDA Label Image

Label (51655 009 52 Rev B 04 21 Nhc)

Label (51655 009 52 Rev B 04 21 Nhc)
Label for Fenofibrate Tablets 160 mg oral tablets, packaged in a 30-tablet container. The label includes storage instructions to keep the product at 20°-25°C, keep out of reach of children, and retain in the original container. It also states the product is prescription-only and manufactured by Northwind Health Company, LLC, with the NDC 51655-009-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.